The potential role of Gliptins to fight COVID-19
Francesco Ferrara and Antonio Vitiello
The clinical rationale of Sacubitril/valsartan for therapeutic treatment in Sars-CoV-...
Francesco Ferrara and Antonio Vitiello
Sacubitril/Valsartan and SARS-CoV-2
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara, et al.
Colchicine and SARS-CoV-2 prospects for clinical management of the inflammatory state
Antonio Vitiello and Francesco Ferrara
The impact of COVID-19 in diabetic patient
Antonio Vitiello and Francesco Ferrara
Are multiple sclerosis therapies safe in SARS-Cov-2 times?
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
Active agents of Renin Angiotensin System and SARS-CoV-2
Antonio Vitiello, Raffaele La Porta, Giovanni Granata, et al.
Plasma Therapy in the fight against Sars-CoV-2: what boils in the pot.
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta, et al.
A shift to avoid Covid-19 risk and safeguard health governance
Francesco Ferrara and Antonio Vitiello
Clinical and phamacological analysis of Sars Cov 2: how combination therapy makes che...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
Clinical pharmacology aspects in patients treated with TNF inhibitors during SARS-Cov...
Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara, et al.
The added value of pirfenidone to declare war on inflammation and the fibrotic state...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.